Breeze Meds review
Breeze Meds is a Georgia-based telehealth provider offering compounded semaglutide ($199/mo), tirzepatide ($399/mo), and NAD+ ($169/mo) across all 50 states.
Breeze Meds publishes its price before the medical intake — you can see what it costs without handing over your health history first.
On this page
- Semaglutide
- From $199/mo (compounded)
- Tirzepatide
- From $399/mo (compounded)
- Coverage
- All 50 states
- Price visible
- Before intake
The verdict
Breeze Meds prints its price before the medical intake and holds up under the rest of the same question — what the figure is attached to, who compounds the medicine, and whether the seller stands behind the number it advertises. That puts it at 2 of 35 on this page.
The number beside Breeze Meds's name answers one question — can you find out what this costs before you hand over your medical history? — and it is dominated by that. A program is credited for naming the pharmacies that compound its medicine and for publishing a certification credential, and docked when the advertised rate needs a commitment, when a second fee sits outside it, when the seller's own terms say the published figure is not what it will charge, and when the FDA has a warning letter on file. What the price turns out to be is not an input at all, which is why a cheaper program can sit below a dearer one here.
Who it is for, and who it is not
A good fit if
You want to compare before you hand anything over
Breeze Meds publishes what it charges before the medical intake, so you can weigh it against anything else on this page without first giving a company your health history.
You want to know who makes the medicine
It names Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx publicly. A compounded medicine is only as good as the pharmacy that made it, and a company willing to name one is a company you can go and check.
You want the openest option rather than the cheapest
It is in the top band of this page on the question we score, which is about what you can find out before you commit rather than about what the medicine costs.
What it actually costs
Both figures below are reproduced exactly as we recorded them, with every condition attached. They are long on purpose: a monthly rate quoted without the term that buys it, the cadence it is billed on, or the dose it applies to is the single most common way a price on a page like this turns out to be untrue.
From $199/mo (compounded)
From $399/mo (compounded)
All 50 states
Breeze Meds pays us a commission if you start care through this link — as does every company with a review here, which is what decides who gets one, so this is not a survey of the market. See our disclosure, and weigh the trade-offs above against the evidence rather than taking our word for it. Breeze Meds sells a prescription medicine, not a probiotic; this site's ranked shelf is the metabolic probiotic ranking, and a supplement is a different decision from a drug.
The pharmacy behind the medicine
It names its pharmacy. Breeze Meds discloses Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx as its compounding partners. That matters more here than the price does: a compounded medicine is only as good as the pharmacy that made it, and a company willing to name one is a company you can go and check.
A compounded drug is mixed to order by a pharmacy rather than manufactured and released as a finished product, so the FDA has not reviewed the specific preparation you are prescribed for safety, effectiveness or quality. That is true of every compounded program on this page, including the ones that score highest, and it is the most important sentence on it.
The honest read
What it does well
- Available in all 50 states
- LegitScript Certified
- Publicly named medical team: Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD
- Four named 503A pharmacy partners: Belmar, Strive, Epiq Scripts, and Casa Pharma Rx
What to check first
- Shares the same clinician network and pharmacies as Care Bare Rx and Synergy Rx — three storefronts on one operation, not independent providers
- Compounded medications are not FDA-approved
- Compounded vs. brand-name sourcing is unclear on the product pages
- Compounded medications are not FDA-approved finished products
How it compares
Breeze Meds sits at 2 of 35 on this page. Every prescription GLP-1 program this site links out to is scored on the same question: can you see the price before you hand over your health history? The full list is on the prescription GLP-1 review index.
Because Breeze Meds prints a figure before the intake rather than after it, it is also a ranked row on our GLP-1 telehealth ranking, our compounded semaglutide ranking and our compounded tirzepatide ranking. Each is this same question narrowed to the programs that answer it, with every figure printed as we recorded it and its conditions attached rather than trimmed to fit a column.
- System Labs review
$179/mo standing, $99 for the first month (compounded, sold only as "GLP-1/GIP" — its lander never names the molecule, so this is the same product as the cell beside it)Show the full pricing note
- Enhance MD review
$249/mo month-to-month (compounded weekly injection, flat at every dose — the advertised $212/mo is the 12-month-plan rate, billed every 48 weeks)Show the full pricing note
- SnagRx review
$99/mo month-to-month (compounded weekly injection, the same price at every dose in SnagRx's own words; $89/mo on 3 months, $79 on 6, $69 only on 12)Show the full pricing note
- Trimi Health review
From $99/mo (all doses, compounded)
- HealthRX review
$190/mo month-to-month (compounded weekly injection, the same price at every dose; a new patient's first month is $99, then $133/mo on 3 months, $119 on 6, and $99 only on 12)Show the full pricing note
Read this before you start
Checked on Breeze Meds's own site on . Prices change — confirm on Breeze Meds's own site before you commit. This page is informational and not medical advice: a GLP-1 is a prescription drug, and whether one suits you is a decision for a licensed clinician who knows your history. How we choose what appears here, and what we are paid for, is set out in our editorial policy.